Pharmaceutical Policy Analysis
This course will give students insight into current developments in pharmaceutical policy making. It will also give them a better understanding of the methods available for analysing the effects of policy interventions. It is an intensive programme covering the topics of pharmaceutical policy analysis issues and methods, current challenges in drug innovation, universal health coverage, regulatory issues and challenges, country profiles, policy and politics, synthesis, case studies and public health. As a collaborator on this course, the World Health Organization will provide lecturers for several of the sessions.
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.
Course director
Prof. dr. Aukje Mantel-Teeuwisse
Lecturers
Prof. Dr. Bert Leufkens, Prof. Dr. Aukje Mantel-Teeuwisse, Dr, Rianne van den Ham and other UU and WHO staff members.
Course Aim
The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
Study load
1 week full time
Costs
Course fee
€ 975.00
Housing fee
€ 200.00
Housing through Utrecht Summer School
The course can be combined with the courses M8 - Pharmacoepidemiology and Drug Safety to receive a discount. When combined with this course, the discount will be € 200.00 per course.
For more information click "LINK TO ORIGINAL" below.
This opportunity has expired. It was originally published here:
https://www.utrechtsummerschool.nl/courses/life-sciences/pharmaceutical-policy-analysis